secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2026-07-31T12:30:15+00:00
Accession:  0001493152-26-035553
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics raises ~$2.67M via warrant exercise; issues new warrants for 3.4M shares
--------------------------------------------------------------------------------

- Gross proceeds of ~$2.67M from cash exercise of 1,702,362 existing warrants at $1.571/share.
- New warrants to purchase up to 3,404,724 shares at $1.56/share, exercisable only after stockholder approval.
- Outstanding shares to increase from 5,277,846 to 6,980,208 after the exercise.
- Placement agent Maxim Group LLC receives 7% cash fee and $50,000 expense reimbursement.
- Net proceeds to be used for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226035553/0001493152-26-035553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226035553/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-035553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer